Income statement, balance sheet and cash flow statement for the last 3 fiscal years, taken from the XBRL data Fatpipe Inc/UT files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2025
FY2025
FY2026
Revenue
17.9
16.3
19.2
Cost of revenue
1.07
1.06
1.73
Gross profit
16.8
15.2
17.5
Research and development
1.79
1.91
Selling and marketing
3.4
3.75
4.79
General and administrative
3.15
3.42
4.76
Operating expenses
11.2
11.8
13.9
Operating income
5.64
3.47
3.59
Interest expense
0.3
0.33
0.4
Interest income
0.03
0.04
0.13
Other non-operating income
-0.04
-0.18
-0.1
Pre-tax income
5.6
3.29
3.49
Income tax
1.44
1.29
-1.48
Net income to minority interests
-0.09
-0.01
Net income
4.37
1.97
4.97
EBITDA
6.34
4.02
3.96
EPS, basic
0.35
0.15
0.36
EPS, diluted
0.35
0.15
0.35
Shares, basic (weighted)
12.4
12.9
13.9
Shares, diluted (weighted)
12.4
12.9
14
Balance sheet
FY2025
FY2025
FY2026
Cash and equivalents
1.11
2.92
5.21
Receivables
3.16
3.76
4.3
Inventory
0.11
0.42
0.45
Other current assets
0.58
0.67
0.13
Total current assets
9.34
13
16.5
Property, plant and equipment
0.08
0.06
0.1
Lease right-of-use assets
0.2
1.46
1.04
Intangible assets
1.56
1.05
0.69
Other non-current assets
0.19
0.38
0.37
Total assets
21.4
28.3
34.5
Accounts payable
0.42
0.44
0.39
Accrued liabilities
2.5
3.86
1.99
Deferred revenue
1.52
1.36
1.09
Short-term debt
0.33
0.39
Total current liabilities
4.72
6.49
4.27
Lease liabilities
0.05
1.11
0.68
Other non-current liabilities
0.12
0.12
0.12
Total liabilities
7.39
12.4
9.31
Total debt
4.97
4.62
Paid-in capital
1.52
1.59
6.1
Retained earnings
9.04
11.1
16.1
Other comprehensive income
3.25
3.1
2.91
Shareholders' equity
13.9
15.9
25.2
Minority interests
0.11
Total equity
14.1
15.9
25.2
Total liabilities and equity
21.4
28.3
34.5
Shares outstanding
12.4
13
14
Cash flow statement
FY2025
FY2025
FY2026
Net income
4.28
1.95
4.97
Depreciation and amortization
0.7
0.55
0.37
Stock-based compensation
0.77
Change in receivables
-0.69
-1.1
-0.72
Change in inventory
0.24
-0.31
-0.03
Change in payables
0.18
0.02
-0.05
Cash from operations
-0.36
-0.5
-0.78
Capital expenditures
-0.02
-0.02
-0.05
Cash from investing
-0.02
-0.02
-0.05
Stock issued
0.08
Cash from financing
0.21
2.49
3.32
Exchange rate effect
0.21
-0.15
-0.19
Net change in cash
0.04
1.81
2.29
Free cash flow
-0.38
-0.52
-0.83
Interest paid
0.3
0.33
0.48
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $5.31 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
90.7%
Gross profit / revenue.
Operating margin
17.2%
Operating income / revenue.
EBITDA margin
17.8%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
16.7%
Pre-tax income / revenue.
Net margin
26.9%
Net income / revenue.
Operating cash flow margin
-4.7%
Cash from operations / revenue.
Effective tax rate
-61.1%
Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)
20.6%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
15.4%
Net income / average total assets.
Return on invested capital (ROIC)
10.3%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue
4.8%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
0.6%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
17.9%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
14.8%
Gross profit vs the same period a year earlier. Only from a positive base.
Operating income growth, 1y
3.4%
Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y
-1.5%
EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y
152.7%
Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y
133.3%
EPS vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
58.3%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
22.0%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
8.9%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
3.98x
Current assets / current liabilities.
Quick ratio
2.03x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.05x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.17x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
12.8%
Total debt / total assets.
Liabilities / assets
25.3%
Total liabilities / total assets.
Net debt
$223.2K
Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA
0.06x
Net debt / EBITDA (twelve months), when EBITDA is positive.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
$0.39
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$1.44
Revenue / diluted weighted shares.
Operating cash flow per share
-$0.07
Cash from operations / diluted weighted shares.
Book value per share
$1.88
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/E
13.8x
Market cap / net income. Only when net income is positive.
P/S
3.69x
Market cap / revenue.
P/B
2.83x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
2.90x
Market cap / tangible book value, when positive.
EV/Sales
3.71x
Enterprise value / revenue.
EV/EBIT
21.6x
Enterprise value / operating income, when both are positive.
EV/EBITDA
20.9x
Enterprise value / EBITDA, when both are positive.
Earnings yield
7.3%
Net income / market cap (the inverse of P/E).
What was Fatpipe Inc/UT's revenue in fiscal 2026?
Fatpipe Inc/UT reported revenue of $19.2M for fiscal 2026, 17.9% higher than the year before.
Was Fatpipe Inc/UT profitable in fiscal 2026?
Yes. Net income was $5.0M, a net margin of 25.9%.
How much free cash flow did Fatpipe Inc/UT generate in fiscal 2026?
Cash from operations of $780.4K minus capital expenditures of $52.5K left free cash flow of -$832.9K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.